Gregory L. Shiferman is of Sage Therapeutics, Inc.. Currently has a direct ownership of 19,888 shares of SAGE, which is worth approximately $122,112. The most recent transaction as insider was on Dec 24, 2024, when has been sold 79 shares (Common Stock) at a price of $5.48 per share, resulting in proceeds of $432. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.9K
n/a 3M change
n/a 12M change
Total Value Held $122,112

Gregory L. Shiferman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 24 2024
SELL
Payment of exercise price or tax liability
$432 $5.48 p/Share
79 Reduced 0.4%
19,888 Common Stock
Nov 01 2024
BUY
Grant, award, or other acquisition
-
5,000 Added 20.03%
19,967 Common Stock
GLS

Gregory L. Shiferman

Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Track Activities on SAGE